Jack W. Callicutt
2016
In 2016, Jack W. Callicutt earned a total compensation of $503.9K as Chief Financial Officer at Galectin Therapeutics, a 18% increase compared to previous year.
Compensation breakdown
| Bonus | $54,172 |
|---|---|
| Option Awards | $140,587 |
| Salary | $260,000 |
| Other | $49,097 |
| Total | $503,856 |
Callicutt received $260K in salary, accounting for 52% of the total pay in 2016.
Callicutt also received $54.2K in bonus, $140.6K in option awards and $49.1K in other compensation.
Rankings
In 2016, Jack W. Callicutt's compensation ranked 11,137th out of 14,075 executives tracked by ExecPay. In other words, Callicutt earned more than 20.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,137 out of 14,075 | 21st |
Division Manufacturing | 4,322 out of 5,486 | 21st |
Major group Chemicals And Allied Products | 1,546 out of 1,900 | 19th |
Industry group Drugs | 1,247 out of 1,543 | 19th |
Industry Pharmaceutical Preparations | 967 out of 1,173 | 18th |
Source: SEC filing on November 7, 2017.
Callicutt's colleagues
We found two more compensation records of executives who worked with Jack W. Callicutt at Galectin Therapeutics in 2016.